Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core Pathways-Reference-Cited by-同舟云学术

Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core Pathways

Published:2018-09-03 Issue:3 Volume:3 Page:544-559
ISSN:2472-1972
Container-title:Journal of the Endocrine Society
language:en
Short-container-title:

Author:

Clarke Callisia N¹^ORCID,Katsonis Panagiotis²,Hsu Teng-Kuei³,Koire Amanda M⁴,Silva-Figueroa Angelica⁵,Christakis Ioannis⁵,Williams Michelle D⁶,Kutahyalioglu Merve⁷,Kwatampora Lily⁷,Xi Yuanxin⁸,Lee Jeffrey E⁵,Koptez E Scott⁹,Busaidy Naifa L⁷,Perrier Nancy D⁵,Lichtarge Olivier²

Affiliation:

1. Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin

2. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas

3. Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas

4. Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, Texas

5. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

6. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

7. Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas

8. Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas

9. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Funder

National Institutes of Health

The Baylor College of Medicine Comprehensive Cancer Training Program

MD Anderson Cancer Center Parathyroid Cancer Research Grant

Publisher

The Endocrine Society

Subject

Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jes/article-pdf/3/3/544/27769731/js.2018-00043.pdf

Reference50 articles.

1. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report;Hundahl;Cancer,1999

2. Parathyroid carcinoma: a 22-year experience;Busaidy;Head Neck,2004

3. Oncologic progress for the treatment of parathyroid carcinoma is needed;Christakis;J Surg Oncol,2016

4. Silva-Figueroa AM , HessKR, WilliamsMD, ClarkeCN, ChristakisI, GrahamPH, GrubbsEG, LeeJE, BusaidyNL, PerrierND. Prognostic scoring system to risk stratify parathyroid carcinoma [published online ahead of print 15 March 2017]. J Am Coll Surg. doi: 10.1016/j.jamcollsurg.2017.01.060.

5. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge;Tomczak;Contemp Oncol (Pozn),2015

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of surufatinib in the treatment of advanced parathyroid carcinoma: A case report;Heliyon;2024-09

2. A Comparative Genomic Analysis of Parathyroid Adenomas and Carcinomas Harboring Heterozygous Germline CDC73 Mutations;The Journal of Clinical Endocrinology & Metabolism;2024-07-24

3. Whole-exome Sequencing of Atypical Parathyroid Tumors Detects Novel and Common Genes Linked to Parathyroid Tumorigenesis;The Journal of Clinical Endocrinology & Metabolism;2024-06-28

4. Molecular genetics of parathyroid tumors;Current Opinion in Endocrine and Metabolic Research;2024-03

5. Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?;Surgery;2024-01